An Open Label Data Collection Study of My Connect Post-Op, a Post-Operative Communication Tool

NCT07120191 | Recruiting

• 1 other identifier: CCAI-PostOp-2025-001
• Study Type: observational
• Target: 200
• Locations: 1 country
• Sites: 1

Brief Summary

This open label, multi-center study will collect data from the participant's use of My Connect Post-Op Software as a post-operative communication solution in supporting patient recovery through Technology-Assisted Conversation (TAC). The application will be tested by patients who have undergone total joint replacement as a post-op communication tool. Data will be collected on how effectively the product guides patients through their recovery, identifying potential complications, and providing appropriate recommendations based on structured question pairs.

Conditions

Total Hip Replacement; Total Knee Replacement

Keywords

Total joint replacement; post op communication; AI assisted conversation; artificial intelligence

Outcome Measures

Primary Outcomes (1)

• Collect structured conversation logs

  Collect conversations between the participant and the clinically conversant AI

  From enrollment to the end of treatment at 4 weeks

Study Arms (1)

Adults undergoing total hip or knee replacement surgery

The entire active group will be utilizing the MyConnect Post Op communication tool.

Device: post op communication software

Interventions

post op communication software DEVICE

MyConnect Post Op is a communication tool that utilizes Technology Assisted Conversation to aid in the recovery of total knee and hip replacement patients

Also known as: MyConnect Post Op

Adults undergoing total hip or knee replacement surgery

Eligibility Criteria

• Age: 22 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

community sample from orthopedic practices

You may qualify if:

• Orthopedic patients scheduled for elective joint arthroplasty (single or double knee, or single or double hip replacement surgery).
• Age 22-80 years. Owns a smart phone. Speaks and understands written and spoken English. Ability to give written informed consent.

You may not qualify if:

• Known diagnosis of a psychiatric disorder. Known opioid dependence in the Investigator's opinion that may complicate participation.
• Any condition that in the Investigator's opinion may complicate or preclude the subject from participating in this trial, such as physical impairment or noncooperation

Sponsors & Collaborators

• Concentra AI, inc: lead

Study Sites (1)

Kansas Joint and Spine

Wichita, Kansas, 67226, United States

RECRUITING

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: OTHER
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 6, 2025
• First Posted: August 13, 2025
• Study Start: May 1, 2025
• Primary Completion: October 15, 2025
• Study Completion: November 30, 2025
• Last Updated: August 15, 2025

Record last verified: 2025-08

Locations

US (1)